A woman came to see me recently — referred by a friend who had been coming to SW1 Clinic for years. She had had neurotoxin done elsewhere, twice, and both times the result was the same: a flat, expressionless quality that made her look not refreshed but erased. She described it as looking “like a mask.” Her friend, she noted, had the same treatment with me and looked entirely natural. She wanted to understand why.
The answer has several layers, and most of them come down to anatomy.
Botulinum toxin works by blocking the neuromuscular junction — preventing acetylcholine release, which means the muscle cannot contract. The result, when placed correctly, is a reduction in dynamic wrinkles: the lines formed by movement. The mechanism is the same in every patient. What differs is the muscle anatomy it’s working on, and that varies significantly between Asian and Caucasian faces.
In my practice at SW1 Clinic, this is something I think about with every single treatment. Not as an afterthought, but as the starting point.
The anatomy differences that actually matter
Asian facial musculature tends to be stronger in certain regions and differently distributed compared to Western facial norms. The masseter muscle — the jaw muscle responsible for chewing — is typically more developed in East and Southeast Asian patients. The orbicularis oculi, the muscle ringing the eye, often has different fibre distribution. The frontalis — the forehead muscle — is frequently lower-set in Asian faces, which means the risk of brow ptosis (the brow dropping after treatment) is meaningfully higher if you use dosing protocols designed for Caucasian anatomy.
This is not a minor point. The majority of clinical dosing guidelines, landmark studies, and injection technique literature was developed using Caucasian subjects. When I trained, and when most doctors still train, the reference anatomy is overwhelmingly Caucasian. Applying those same protocols to Asian patients is where things go wrong.
A review published in the Journal of Drugs in Dermatology noted significant differences in facial muscle anatomy between Asian and Caucasian patients, and concluded that injection points and doses needed to be adapted accordingly [1]. More recently, Korean and Singaporean practitioners have been contributing to a growing body of literature on Asian-specific injection mapping — and this is genuinely useful work that is beginning to shift practice standards [2].
The specific issues I see in Asian patients post-treatment
The most common complaint I hear from patients who have had neurotoxin done elsewhere is brow heaviness. This happens when the forehead is treated too aggressively or too low, and the compensatory action of the frontalis — which many Asian patients unconsciously use to lift a naturally lower brow — is removed. The brow drops. The upper eyelid looks heavier. The patient looks tired. Not older, exactly. Just tired. And this is entirely preventable with a proper assessment of brow position before treatment.
The second issue is the frozen look the woman I described at the start was experiencing. This often comes from over-treating the mid-face or using dosing that doesn’t account for the difference in muscle mass. Asian patients don’t necessarily need lower doses — some areas require more, some less — but they require doses calibrated to their specific anatomy, not borrowed from protocols designed for someone with a structurally different face.
The third issue is crow’s feet treatment. Asian patients frequently have a higher density of lower eyelid orbicularis oculi fibre. If crow’s feet treatment extends too inferiorly, it can affect the lower eyelid, causing a temporary but distressing change in eyelid shape. I’ve seen patients come in post-treatment at other clinics with a visible change in their lower lid contour. It resolves. But it was entirely avoidable.
The masseter question
I should address this specifically because masseter botulinum toxin has become extremely popular among Asian patients, particularly in Singapore and across East Asia. The desire for a slimmer jawline is cultural and widespread — I understand it. The treatment, when done well, does reduce masseter bulk and can create a softer facial contour.
But I see overdone masseter treatments regularly. When the masseter is significantly reduced, several things happen: chewing mechanics change, the lower face can lose structural support, and in patients with any pre-existing bone loss, the jawline can develop a gaunt quality over time. The youthful V-line that the patient wanted in their 30s can become a structural problem in their 40s.
My approach is conservative. Smaller doses. More frequent reassessment. The goal is a subtle contour change, not a dramatic reduction. Faces change over time, and the masseter provides structural support that we should not be cavalier about removing.
Anti-wrinkle injections at SW1 Clinic are always preceded by a full facial assessment — muscle mapping, skin quality, bone structure, and what the patient’s face is doing at rest versus in motion.
What this means practically for you
If you’ve had neurotoxin treatment and felt the result was “off” — too frozen, brow-heavy, or asymmetric — it is worth asking whether the injector was working from Asian-specific anatomical knowledge or applying a generic protocol.
The questions I’d encourage you to ask at any consultation: Has my brow position been assessed? What dose are you using and why? Have you treated many patients with my facial structure?
The right answer to that last question isn’t a number. It’s an explanation — because a practitioner who understands Asian facial anatomy will be able to tell you specifically what they’re thinking about for your face, not just recite a procedure menu.
Good neurotoxin treatment is invisible. That is the standard. You don’t look treated; you look like a slightly better-rested, slightly more at-ease version of yourself. When it goes wrong, it’s usually because the starting point — the anatomical assessment — was done in too much of a hurry, or not done at all.
I have been treating Asian faces for over twenty years. The thing I’ve learned is that there is no universal template. Every face is its own cartography.
References
[1] Raspaldo, H., et al. (2011). Injecting the upper face with botulinum toxin type A: An updated review. Journal of Cosmetic Dermatology, 10(4), 340–349. https://doi.org/10.1111/j.1473-2165.2011.00590.x [VERIFY — confirm before publishing]
[2] Wu, W. T. L. (2010). Botox facial slimming/facial sculpting: The role of botulinum toxin-A in the treatment of hypertrophic masseter muscle and parotid enlargement to narrow the lower facial width. Facial Plastic Surgery Clinics of North America, 18(1), 133–140. https://doi.org/10.1016/j.fsc.2009.11.014 [VERIFY — confirm before publishing]
[3] Park, M. Y., et al. (2015). Botulinum toxin type A treatment for lower facial contouring in Korean patients. Aesthetic Plastic Surgery, 39(4), 554–563. [VERIFY — confirm before publishing]
